Picture a dispensary with medical and adult-use activity drawing from a common pool of inventory. For this discussion, that is a hypothetical—not a verified description of any particular operator.
The tax question is concrete: does qualifying medical-license coverage attach to the inventory, or is that coverage limited by the medical purpose of a particular activity? The answer can affect how an operator analyzes its expenses under §280E. A common shelf, by itself, does not supply the answer.
Start with the statute and the scheduling entry
IRC §280E disallows deductions and credits for expenditures in a business, or its constituent activities, consisting of prohibited trafficking in Schedule I or II controlled substances. Schedule III is outside that specified range. Whether the relevant activity involves Schedule I or II remains a necessary part of the analysis.
The April 28, 2026 final rule took effect on April 28. The Schedule III entry covers marijuana in an FDA-approved product or “subject to a state medical marijuana license.” Noncovered marijuana remains in Schedule I. See 21 C.F.R. §1308.13(g)(2), current eCFR, and 91 Fed. Reg. 22719, 22722.
That license language creates the shared-inventory debate. It does not settle every operator’s tax liability.
The taxpayer’s inventory-status argument
One proposed reading focuses on the inventory’s qualifying license coverage. If particular stock is covered by a medical license while it is held, the argument asks why a later adult-use sale would, by itself, change the substance’s federal schedule.
The related distinction is between classification and authorization. A limitation on what an operator may do is not necessarily the same thing as a provision changing the classification of the product. The taxpayer would ask which text establishes the alleged change, and how it applies to the identified inventory.
This is an interpretive argument. It depends on proving the relevant license’s scope and the actual inventory facts. It does not establish that merely possessing a medical license converts all stock or adult-use activity into a covered medical operation. Nor does a supplier’s medical license, standing alone, establish the buyer’s treatment.
The strongest opposing reading
A potential government response ties qualifying coverage to medical purpose. The medical license authorizes specified medical activity; the opponent would argue that an adult-use sale falls outside that authority.
The license definition is medical-purpose specific, and the registration provision expressly excludes nonmedical activity from the authority it grants. The preamble also preserves Schedule I treatment for noncovered marijuana. These provisions are substantial obstacles to a reading that would give every dual-license operator blanket relief. See 21 C.F.R. §§1300.01, 1301.13(k)(1)(iv) and 91 Fed. Reg. 22719, 22721–22. The order also expressly leaves individual federal tax liability to a separate determination. See 91 Fed. Reg. 22720.
Calling this a potential government argument is deliberate. We are analyzing competing readings, not announcing a court holding or an IRS determination about a particular taxpayer. An operator considering the broader reading needs to confront this response directly.
What Treasury actually announced
In its April 23, 2026 announcement, Treasury and the IRS described guidance they expected to issue. That included treatment of multiple activities, potentially through expense apportionment, and a generally full-taxable-year transition for activities that no longer involve Schedule I or II substances because of the order.
The announcement’s future-tense wording matters. It is not itself the promised allocation method or transition rule. It also does not answer which shared-inventory activity qualifies. Review the authority in effect when making the actual decision; do not turn an anticipated rule into a guaranteed deduction, refund or filing position.
Put the records beside the argument
The legal theory needs a factual record. Useful questions for an operator and its advisers include:
- Which entity holds each license, and what activity does each license authorize?
- What were the license’s effective dates and the relevant inventory’s acquisition and transfer dates?
- What do supplier records, batch receipts and transfers establish—and what do they leave unknown?
- How are medical and adult-use sales classified and reconciled?
- What supports the expenses being analyzed, and where are the inconsistencies?
These are preparation questions, not instructions to change a tax return. A label, shared shelf or bookkeeping category is evidence to evaluate; it is not a substitute for the legal analysis. A well-supported record helps advisers assess the argument and its limits without promising the result.
Ask what would change the answer
The useful conversation goes beyond whether an operator likes the broader reading. Ask what authority supports it, what the opposing reading explains better, and what missing fact could change the conclusion. Scheduling, permission to conduct an activity and federal tax treatment each require attention.
For the broader framework, read our Schedule III cannabis hub. For a review of your licensing structure and legal questions, contact Cannabis Industry Lawyer and ask about working with Thomas Howard. Coordinate tax-return decisions with your tax adviser. Do not send customer data or confidential tax files through public comments.
Educational legal analysis; not individualized legal or tax advice. No outcome is promised. Reading this article does not create an attorney-client relationship.
